ReviewHuman vaccines & immunotherapeutics2020
Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia.
Review in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Religion, Politics, and Vaccines: Elaborating the Integrative Public Policy Acceptance (IPAC) Framework Through HPV Vaccine Program Acceptance Among Religious Leaders in Bangladesh.International journal of health policy and management · 2026Article
- A comprehensive review of the childhood vaccination landscape in Malaysia.Epidemiology and infection · 2025Review
- Ethnic Disparities in COVID-19 Vaccine Mistrust and Receipt in British Columbia, Canada: Population Survey.JMIR public health and surveillance · 2024Article
- Barriers to measles mumps rubella vaccine acceptance in the three southern border provinces of Thailand.Clinical and experimental vaccine research · 2023Article
- Acceptability for COVID-19 vaccination: perspectives from Muslims.Human vaccines & immunotherapeutics · 2022Article
- Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment.The Lancet regional health. Western Pacific · 2022Article
- Article
- Role of Religious Leaders in COVID-19 Prevention: A Community-Level Prevention Model in Sri Lanka.Journal of religion and health · 2022Article
- Trust about corona vaccine among health professionals working at Dilla University referral hospital, 2021.Vaccine: X · 2021Article
- Cell-based influenza vaccine: current production,Human vaccines & immunotherapeutics · 2021Article
- COVID-19 Vaccine Acceptability and Adherence to Preventive Measures in Somalia: Results of an Online Survey.Vaccines · 2021Article
- COVID-19 Vaccination Intent and Willingness to Pay in Bangladesh: A Cross-Sectional Study.Vaccines · 2021Article
- Article
- Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia.Human vaccines & immunotherapeutics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recommendations on new vaccines, outline the different steps in decision-making on incorporating a new vaccine into the National Immunization Program, describe its issues and challenges, and explore the commercial viability and challenges of producing local permissible (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.